An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system
Authors:
- 1 January 2015
- journal article
- Published by Walter de Gruyter GmbH in Immunohematology
- Vol. 31 (2) , 62-68
Abstract
Automated testing platforms facilitate the introduction of red cell genotyping of patients and blood donors. Fluidic microarray systems, such as Luminex XMAP (Austin, TX), are used in many clinical applications, including HLA and HPA typing. The Progenika ID CORE XT (Progenika Biopharma-Grifols, Bizkaia, Spain) uses this platform to analyze 29 polymorphisms determining 37 antigens in 10 blood group systems. Once DNA has been extracted, processing time is approximately 4 hours. The system is highly automated and includes integrated analysis software that produces a file and a report with genotype and predicted phenotype results. Immunohematology 2015;31:62–68.Keywords
This publication has 3 references indexed in Scilit:
- Technologies involved in molecular blood group genotypingISBT Science Series, 2011
- The BloodGen project: toward mass‐scale comprehensive genotyping of blood donors in the European Union and beyondTransfusion, 2007
- Applications of Luminex® xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detectionClinica Chimica Acta, 2006